Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Will economic drivers create a market shift to more reusable temperature-controlled shipping containers around the globe?

An interview with Pelican BioPharma’s Director of Business Development, Jeff Wodrich, and VP of Sales Kevin Lawler.

Pelican Products Inc., designer and manufacturer of protective case products and portable lighting systems recently acquired Minnesota Thermal Science, a global cold chain logistics supplier.

Healthcare Packaging: Clearly, we keep hearing about the growth of biologics and the inherent problems of shipping more sensitive “large-molecule” medicines. How does Pelican see this growth affecting the supply chain?

Jeff Wodrich: We see an increased need for cold chain packaging solutions that offer not only more thermal protection, but added security and more cost-effectiveness—lower total cost of ownership.

Kevin Lawler:  Everyone talks about major pharmaceutical companies being faced with expiring patents. One change we see is increased acquisitions in a race to get new drugs in the pipeline. The other significant change is cost-reduction initiatives.

Healthcare Packaging: And that’s where this notion of reusability comes into play. For very expensive drugs moving long distances, a more expensive container only makes sense if it can be used over and over.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?